Conversely, the marked overexpression of the transporter protein ABCC4 in prostate cancer, compared to other solid tumors, indicates that the preferential export of pge2 from cancer cells is the predominant source of its elevated levels in prostate cancer (over-export). Here, ABCC4 is linked to prostate carcinoma.